navtemadlin
kartos therapeutics
['mpnsm', '#mpn', 'krt-232', 'aml,(-streamline),(-seamless),(-kamloops)']
congress #asco22 | presents the design of a phase ib/ii study of krt-232 in pts with r/r aml secondary to #mpn. primary endpoint: recommended phase ii dose of krt-232. 2ndary endpoints: cr rates, crh, cri, orr, dor, pfs, os, and safety. #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm